The First Hospital of Jilin University
Changchun, Jilin, 130021, China
Location status: Recruiting
NCT Number: NCT07151885
To evaluate the diagnostic value of the combined model of subharmonic-assisted pressure estimation (SHAPE), liver stiffness (LSM), and platelet count (PLT) for high-risk esophageal and gastric varices (HRV)
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Changchun, Jilin, 130021, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use an ultrasound probe to scan the liver to locate the portal vein and hepatic vein. In the angiography mode, the portal vein and hepatic vein of the same depth were selected for measurement respectively. Ultrasound contrast agent was injected through the elbow vein to observe the changes of sub-harmonic signals in the portal vein and hepatic vein. Collect the sub-harmonic signal data of the portal vein and hepatic vein, and calculate the difference between the two, that is, the SHAPE gradient.
Time frame: Within two weeks of admission
The difference in the average harmonic signal between the hepatic vein and the portal vein
Time frame: Within two weeks of admission
The patient lies on their back, with their right hand placed behind their head. The right upper limb is fully abducted to expose the intercostal Spaces in the right lobe of the liver. The area usually enclosed by the horizontal line of the xiphoid process, the midline of the right axilla and the lower edge of the rib is taken as the testing area. The probe is vertically and closely attached to the skin, and the measurement position is selected in the intercostal space.
Time frame: Within two weeks of admission
The peripheral blood of the patient was tested by a conventional blood analyzer to obtain the platelet count.
Time frame: The one-year period from enrollment to the end of the group
The sensitivity measures the ability of the model to correctly identify patients with HRV (i.e., the true positive rate), and the specificity measures the ability of the model to correctly exclude patients without HRV (i.e., the true negative rate).
Time frame: The one-year period from enrollment to the end of the group
PPV represents the probability that patients identified as high-risk by the model actually have HRV, while NPV represents the probability that patients identified as low-risk by the model do not actually have HRV
Time frame: The one-year period from enrollment to the end of the group
Comprehensively reflect the overall discriminative ability of the model under different thresholds
Contact information is provided by the study sponsor or research team.
The First Hospital of Jilin University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07248722
Digestive System Diseases, Esophageal Diseases
Shenyang, Liaoning, China
View Trial DetailsNCT04823780
Digestive System Diseases, Esophageal Diseases
Jinan, Shandong, China
View Trial DetailsNCT02593799
Digestive System Diseases, Esophageal Diseases
Anshan, Liaoning, China
View Trial DetailsNCT00006398
Digestive System Diseases, Esophageal Diseases
New Haven, Connecticut, United States
View Trial Details